78 results
Page 3 of 4
424B7
rrlkk7cxgns1n4f da
11 Feb 21
Prospectus with selling stockholder info
5:15pm
8-K
gfwstkgf0ugjcdi
12 Jan 21
Other Events
7:44am
425
qks2d3r6ihr2
12 Jan 21
Business combination disclosure
7:42am
DEFM14A
jli3jt9e3gwm sw6
15 Dec 20
Proxy related to merger
9:26am
424B3
fm5p6eeem5bt
15 Dec 20
Prospectus supplement
9:22am
S-4/A
lu2cmr3zthso 3z
11 Dec 20
Registration of securities issued in business combination transactions (amended)
7:11am
S-4
u7jpitlau rasq
6 Nov 20
Registration of securities issued in business combination transactions
5:05pm
8-K
EX-99.1
n5n9thx
5 Nov 20
BridgeBio Pharma, Inc. Reports Third Quarter 2020 Financial Results And Business Update
8:00am
425
grewlbmx
5 Oct 20
Business combination disclosure
9:58pm
8-K
EX-99.2
j6pjfpi5bqf6dlz c6lx
5 Oct 20
Bridgebio Pharma and Eidos Therapeutics Announce Merger Agreement
5:19pm
425
EX-99.2
r3zxso4pan cb1r5
5 Oct 20
Business combination disclosure
5:17pm
8-K
EX-99.1
1za45 by5z
29 Sep 20
Regulation FD Disclosure
7:01am
8-K
EX-99.1
gvc mnylvb
11 Aug 20
BridgeBio Pharma, Inc. Reports Second Quarter 2020 Financial Results and Business Update
8:03am
S-3ASR
amy eunac
28 Jul 20
Automatic shelf registration
4:45pm
S-3ASR
4b8san8e9w6 da
7 Jul 20
Automatic shelf registration
5:28pm
8-K
EX-99.1
k61ysay2
13 May 20
BridgeBio Pharma, Inc. Reports First Quarter 2020 Financial Results and Business Update
4:27pm
DEF 14A
wiri7tj r7
22 Apr 20
Definitive proxy
5:22pm